• Torin2 in Cancer Research: Precision mTOR Inhibition and Ass

  2026-06-13

  Explore how Torin2, a potent mTOR inhibitor, is revolutionizing cancer research through detailed mechanistic action, advanced in vitro assay design, and practical protocol guidance. This article offers unique insights into Torin2's selectivity and real-world applications.

• Essential Fe–S Cluster in DNA Polymerase ε Catalytic Core: S

  2026-06-12

  This study provides direct structural evidence for a single iron–sulfur (Fe–S) cluster in the catalytic core (Pol2CORE) of DNA polymerase ε, demonstrating its essential role in polymerase activity and cell viability. These findings clarify a longstanding debate regarding Fe–S cluster localization and function in eukaryotic replicative polymerases, with significant implications for understanding genome replication fidelity.

• DiscoveryProbe™ Metabolism-related Compound Library: Technic

  2026-06-12

  The DiscoveryProbe™ Metabolism-related Compound Library addresses the need for high-quality, functionally diverse small molecules to interrogate metabolic pathways and enzyme targets in vitro and ex vivo. It enables reproducible metabolic enzyme inhibition assays and pathway modulation, but is not suitable for diagnostic or clinical applications.

• Vemurafenib (PLX4032, RG7204): Reliable Workflows for Melano

  2026-06-11

  This article delivers scenario-driven, evidence-backed guidance for researchers applying Vemurafenib (PLX4032, RG7204) (SKU A3004) in cell viability and tumor regression assays. It addresses practical laboratory challenges, protocol optimization, and resistance analysis, with insights grounded in both product data and peer-reviewed studies. APExBIO’s Vemurafenib (A3004) is highlighted for its reproducibility and compatibility within advanced cancer biology workflows.

• ORAI2-Mediated SOCE Drives Early Salivary Gland Fibrosis Pos

  2026-06-11

  This study identifies ORAI2 as a pivotal regulator of early-stage postirradiation fibrosis in salivary glands, acting through a newly defined ORAI2/JNK/NFAT1/TGF-β1 axis. Pharmacological inhibition of SOCE and NFAT1 mitigated fibrosis and restored gland function, offering new molecular targets for intervention.

• Applied Workflows with EZ Cap EGFP mRNA 5-moUTP for Gene Exp

  2026-06-10

  EZ Cap™ EGFP mRNA (5-moUTP) enables robust, reproducible gene expression with superior translation efficiency and minimal immunogenicity. This guide delivers practical, evidence-based workflows, advanced use-cases, and troubleshooting strategies for maximizing experimental success in mRNA delivery and in vivo imaging applications.

• MCC950 Sodium: Precision NLRP3 Inhibition for Inflammatory M

  2026-06-10

  MCC950 sodium (CRID3 sodium salt) empowers researchers to dissect NLRP3 inflammasome signaling in both murine and human macrophage systems with nanomolar selectivity. This guide delivers actionable protocols, troubleshooting strategies, and cross-study insights leveraging APExBIO’s high-purity inhibitor for reliable inflammatory disease research.

• Toremifene Citrate in Breast Cancer: Beyond SERM to Precisio

  2026-06-09

  Explore how Toremifene Citrate, a leading oral selective estrogen receptor modulator, advances precision in breast cancer research with mechanistic clarity and protocol insights. This in-depth guide uniquely evaluates its translational value for personalized medicine.

• Dacarbazine: Experimental Workflows in Antineoplastic Chemot

  2026-06-09

  Dacarbazine stands out as an antineoplastic chemotherapy drug with proven efficacy in DNA alkylation for cancer research. This article details optimized protocols, advanced troubleshooting, and workflow innovations that unlock reliable results for translational oncology labs working in malignant melanoma, Hodgkin lymphoma, and sarcoma models.

• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-06-08

  The referenced dissertation by Hannah R. Schwartz introduces a nuanced approach to measuring anti-cancer drug efficacy in vitro by distinguishing between proliferative arrest and cell death. This innovation improves the reliability and interpretability of preclinical drug screening, directly impacting the development of antineoplastic chemotherapy agents such as dacarbazine.

• ATRX Loss Sensitizes High-Grade Glioma to PDGFR Inhibition

  2026-06-08

  The reference study reveals that high-grade glioma cells with ATRX deficiency exhibit heightened sensitivity to receptor tyrosine kinase (RTK) and PDGFR inhibitors. This finding suggests that ATRX status could inform therapeutic strategies and clinical trial interpretations in glioma treatment.

• Dosage Sensitivity of Loop Extrusion Tunes Genome Folding Dy

  2026-06-07

  This study uncovers how the rate of cohesin-mediated DNA loop extrusion, modulated by cofactors NIPBL and PDS5, serves as a tunable parameter for genome organization. The findings explain both the adaptive flexibility and genetic vulnerability of chromosome folding, providing new mechanistic insight into cohesinopathies like Cornelia de Lange syndrome.

• Streptavidin-FITC: Precision Fluorescent Detection in Biotin

  2026-06-06

  Streptavidin-FITC stands out for ultrasensitive fluorescent detection of biotinylated targets, enabling high-throughput analysis from immunohistochemistry to advanced nanoparticle tracking. This guide details optimized workflows, integration with cutting-edge lipid nanoparticle studies, and expert troubleshooting—anchored by APExBIO’s trusted quality.

• Cholesterol Impairs Intracellular Trafficking of Lipid Nanop

  2026-06-05

  This study reveals that increasing cholesterol content in lipid nanoparticles (LNPs) disrupts their intracellular trafficking, leading to peripheral endosomal trapping and reduced delivery of nucleic acid cargo. The findings provide mechanistic insight into nanoparticle formulation and highlight the value of advanced fluorescent tracking methods for studying LNP dynamics.

• Estradiol Benzoate: Strategic Leverage for ERα Signaling Res

  2026-06-05

  Explore how Estradiol Benzoate, a synthetic estrogen receptor alpha agonist, provides translational researchers with precise mechanistic tools and workflow optimizations. This article bridges foundational biology, experimental rigor, and future-facing strategies, integrating competitive landscape analysis and cross-referencing key literature and authoritative protocols for robust, reproducible results.

16992 records 4/1133 page Previous Next 12345 下5页 Last page